Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.

Shi H, Wang S, Curtiss R 3rd.

Clin Vaccine Immunol. 2013 Jun;20(6):931-44. doi: 10.1128/CVI.00003-13. Epub 2013 Apr 24.

2.

A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.

Frey SE, Lottenbach KR, Hill H, Blevins TP, Yu Y, Zhang Y, Brenneman KE, Kelly-Aehle SM, McDonald C, Jansen A, Curtiss R 3rd.

Vaccine. 2013 Oct 1;31(42):4874-80. doi: 10.1016/j.vaccine.2013.07.049. Epub 2013 Aug 3.

PMID:
23916987
3.

PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Xin W, Li Y, Mo H, Roland KL, Curtiss R 3rd.

Infect Immun. 2009 Oct;77(10):4518-28. doi: 10.1128/IAI.00486-09. Epub 2009 Aug 17.

5.
7.

Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.

Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R 3rd.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):593-8. doi: 10.1073/pnas.0811697106. Epub 2008 Dec 29.

8.

Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Xin W, Wanda SY, Li Y, Wang S, Mo H, Curtiss R 3rd.

Infect Immun. 2008 Jul;76(7):3241-54. doi: 10.1128/IAI.01623-07. Epub 2008 May 5.

9.

A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.

Kothari N, Kothari S, Choi YJ, Dey A, Briles DE, Rhee DK, Carbis R.

Vaccine. 2015 Feb 4;33(6):783-8. doi: 10.1016/j.vaccine.2014.12.032. Epub 2014 Dec 26.

PMID:
25545593
10.

Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.

Han YW, Kim SB, Rahman M, Uyangaa E, Lee BM, Kim JH, Park KI, Hong JT, Han SB, Eo SK.

Comp Immunol Microbiol Infect Dis. 2011 Jul;34(4):335-45. doi: 10.1016/j.cimid.2011.04.001. Epub 2011 May 2.

PMID:
21543119
11.

Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.

Haneda T, Okada N, Kikuchi Y, Takagi M, Kurotaki T, Miki T, Arai S, Danbara H.

Comp Immunol Microbiol Infect Dis. 2011 Sep;34(5):399-409. doi: 10.1016/j.cimid.2011.07.001. Epub 2011 Aug 12.

PMID:
21840053
12.

Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H.

Infect Immun. 2013 May;81(5):1625-34. doi: 10.1128/IAI.00240-13. Epub 2013 Mar 4.

13.
14.
15.

Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.

Shi H, Wang S, Roland KL, Gunn BM, Curtiss R 3rd.

Clin Vaccine Immunol. 2010 Mar;17(3):363-71. doi: 10.1128/CVI.00413-09. Epub 2010 Jan 6.

16.

Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.

Salcedo-Rivillas C, Debrie AS, Miyaji EN, Ferreira JM Jr, Raw I, Locht C, Ho PL, Mielcarek N, Oliveira ML.

Clin Vaccine Immunol. 2014 Jul;21(7):972-81. doi: 10.1128/CVI.00134-14. Epub 2014 May 7.

17.

Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.

Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.

Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017.

18.

Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.

Ferreira DM, Darrieux M, Oliveira ML, Leite LC, Miyaji EN.

Clin Vaccine Immunol. 2008 Mar;15(3):499-505. doi: 10.1128/CVI.00400-07. Epub 2008 Jan 9.

19.

Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.

Zhang M, Sun C, Gu J, Yan X, Wang B, Cui Z, Sun X, Tong C, Feng X, Lei L, Han W.

Microbiol Immunol. 2015 Sep;59(9):533-44. doi: 10.1111/1348-0421.12291.

20.

Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors.

Khan SA, Stratford R, Wu T, Mckelvie N, Bellaby T, Hindle Z, Sinha KA, Eltze S, Mastroeni P, Pickard D, Dougan G, Chatfield SN, Brennan FR.

Vaccine. 2003 Jan 17;21(5-6):538-48.

PMID:
12531654

Supplemental Content

Support Center